Makkena Investments Inc entered the industry of Blood Related Health Services in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621991, which describes it as a Blood Related Health Services. For further clarification, the SIC classifies this business under the code 8099 and described it as a Blood Related Health Services. The business provides service to the B2C market.
To acquire more information, please contact Ramarao Makkena by calling No number given during business hours. You can also write to the business’ Single Location at 3379 West Vine St # 309, Kissimmee, Florida FL 34741. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Makkena Investments Inc |
| Representative: | Ramarao Makkena |
| Place of Business: | 3379 West Vine St # 309, Kissimmee, FL 34741 |
| Contact Number: | No number given |
| Type of Service: | Blood Related Health Services |
| SIC Number: | 8099 |
| NAICS Number: | 621991 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2009 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Makkena Investments Inc is a company operating from Osceola, Florida providing professional Blood Related Health Services and relevant B2C variables. It was founded in 2009 and registered with the SIC code 8099 as Blood Related Health Services, and with the NAICS code 621991 as Blood Related Health Services.
With a current employee count of 1 to 4, Makkena Investments Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Ramarao Makkena at No number given for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 3379 West Vine St # 309 in Kissimmee, Florida 34741 and can be engaged online through the company website at , the company Twitter , and Facebook page .